InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,544.59
(
-0.78%
)
US TECH 100
19,179.60
(
0.00%
)
Dow Jones
40,665.02
(
-1.29%
)
Brent Oil
83.80
(
-0.34%
)
Bitcoin
64,030.91
(
0.10%
)
Post# of 464448
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 64
Posts 24009
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: BAR123 post# 163290

Tuesday, 08/21/2018 3:22:01 AM

Tuesday, August 21, 2018 3:22:01 AM

Post# of 464448
Good question. My assumption is the complete P2b/3 trial is scheduled to last 48 weeks per patient. By some criteria, not yet known, each patient then seamlessly transition into the P3 stage somewhere along the 48 weeks.

Interesting what others more familiar with trials will say.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM

VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM

Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM

Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM

Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM

HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!